FDA issued a Warning Letter to Magellan Diagnostics, Inc. on 10/23/2017 for a previous inspection.
483 Magellan Diagnostics Oct 2019

483 Magellan Diagnostics Oct 2019

Sara Onyango FDA$119.00 - Available Now

FDA investigators audited the Magellan Diagnostics - North Billerica, MA, United States facility and issued inspectional observations (via FDA 483) on 21 Oct 2019.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 21 Oct 2019
  • Location: North Billerica, United States
  • FEI: 1218996
Add To Cart